CERVICURA
Live / Registered — International registration cancelled — extension of protection cancelled (as of 20 Apr 2025)
What this means for you
Registered since 02 Feb 2016. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79166469
- Registration number
- 4893999
- Mark type
- Word mark
- Filed
- 20 Apr 2015
- Published for opposition
- 17 Nov 2015
- Registered
- 02 Feb 2016
- Attorney of record
- Yoon S. Ham
Goods and services
- Class 005 — Pharmaceuticals: DNA vaccines; Pharmaceutical products and preparations, namely, for the treatment and prevention of human papilloma virus infectious disease, cancer and cervical intraepithelial neoplasia; vaccines; antibiotics; anti-cancer preparations; Drugs for medical purposes, namely, pharmaceutical drug preparations for the treatment and prevention of human papilloma virus infectious disease, cancer and cervical intraepithelial neoplasia; Injectable pharmaceuticals for medical purposes, namely, for the treatment and prevention of human papilloma virus infectious disease, cancer and cervical intraepithelial neoplasia; Cardiovascular pharmaceutical preparations for the treatment and prevention of heart and vascular diseases; Medicines for sensory organs, namely, pharmaceutical preparations for the prevention, treatment, and cure of diseases and conditions impacting the eyes, ears, nose, mouth and nervous system; Pharmaceutical preparations for digestive organs, namely, for the prevention, treatment, and cure of diseases and conditions impacting digestive organs; Dermatological pharmaceutical products; Blood solvent, namely, blood plasma, albumin, globulin, fibrinogen, thrombocyte and platelets; Pharmaceutical agents affecting metabolism; Anti-inflammatory preparations, namely, anti-inflammatory gels, ointments, salves, sprays, creams, pills, powders, granules, tablets, capsules, depots, suppository, syrup, tinctures and emulsion; Therapeutic vaccines; preventive vaccines; Pharmaceutical preparations for immunomodulatory purposes, namely, for the regulation of immune functions; Pharmaceutical preparations for the treatment of cervical cancer; Pharmaceutical preparations for the treatment of cervical intraepithelial neoplasia; pharmaceutical preparations for the treatment of cervical pre-cancer; Pharmaceutical preparations for the treatment of head and neck cancer; Pharmaceutical preparations for immunotherapy; pharmaceutical preparations for anticancer immunotherapy; Pharmaceutical preparations for gene therapy; antiviral agent against human papilloma virus; preventive vaccines against human papilloma virus infections
Owner
- Genexine, Inc., KR
- Genexine, Inc., KR
- Genexine, Inc., KR
- Genexine, Inc., KR
Prosecution history
- 12 Feb 2026 — NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
- 12 Feb 2026 — DEATH OF INTERNATIONAL REGISTRATION
- 15 Nov 2025 — NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
- 15 Nov 2025 — DEATH OF INTERNATIONAL REGISTRATION
- 07 Feb 2025 — NEW REPRESENTATIVE AT IB RECEIVED
- 28 Nov 2024 — CHANGE OF NAME/ADDRESS REC'D FROM IB
- 18 Jun 2023 — TOTAL INVALIDATION PROCESSED BY THE IB
- 24 May 2023 — TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
- 24 May 2023 — INVALIDATION PROCESSED
- 19 Apr 2023 — TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
- 19 Aug 2022 — CANCELLED SECTION 71
- 02 Feb 2021 — COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
- 28 May 2020 — NEW REPRESENTATIVE AT IB RECEIVED
- 09 Jul 2016 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 03 May 2016 — FINAL DISPOSITION NOTICE SENT TO IB